Nakaguchi K, Nakano Y, Kitahara T, Onoe K, Nagamine H, Fukuda H
Dept. of Surgery, Nagahori Hospital.
Gan To Kagaku Ryoho. 1990 Oct;17(10):2101-4.
5'-DFUR was administered orally at 800 mg/day, for total dosage of 57.6 g to the gastric cancer patient, classified Borrmann Type 2, with Virchow's node metastasis. Gastric tumor had diminished in size on the fluoroscopy and the endoscopy. We then made distal gastrectomy. The resected stomach showed moderately differentiated tubular adenocarcinoma on the pathological examination. Side effect was diarrhea.